Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
44 th Annual Meeting<br />
and ToxExpo<br />
<strong>Program</strong> Description<br />
WEDNESDAY<br />
#1648 3:40 EFFECTS OF ENVIRONMENTAL AIR<br />
POLLUTANTS ON POSTNATAL LUNG<br />
DEVELOPMENT. M. Fanucchi. School <strong>of</strong> Veterinary<br />
Medicine, University <strong>of</strong> California, Davis, CA.<br />
Wednesday Afternoon, March 9<br />
1:30 PM to 4:30 PM<br />
Room RO3<br />
SYMPOSIUM SESSION: ROLE OF CELL-CELL AND CELL-MATRIX<br />
INTERACTIONS IN REGULATION OF TOXICANT-MEDIATED CELL<br />
DEATH<br />
Chairperson(s): Ronald Tjalkens, Colorado State University, Fort Collins,<br />
CO.<br />
Endorsed by:<br />
Carcinogenesis SS*<br />
Mechanisms SS<br />
Neurotoxicology SS<br />
Cell-cell interactions are key for the regulation <strong>of</strong> cell survival, cell death and<br />
cell proliferation. Thus, an understanding <strong>of</strong> the interdependency between<br />
different tissue cellular compartments is key to elucidating mechanisms <strong>of</strong> cell<br />
death in response to toxicants. This symposium will provide a timely update on<br />
the molecular mechanisms <strong>of</strong> cell death and its regulation, including the role<br />
played by cell-cell and cell-matrix interactions. This will be illustrated by three<br />
examples <strong>of</strong> the role these pathways play in toxicant response in diverse tissues.<br />
The first speaker will consider how hepatic Kupffer cells are implicated in<br />
normal homeostasis and in hepatocarcinogenesis and can mediate both hepatocyte<br />
survival or cell death, depending on the toxic insult. The second speaker<br />
will address how gap junctional intercellular communication and cell adhesion<br />
are interrelated processes using the example <strong>of</strong> hexachlorobenzene which<br />
induces a down-regulation <strong>of</strong> connexins and E-cadherin in the liver <strong>of</strong> female<br />
but not male rats. The third speaker brings an external perspective and will<br />
discuss how the cell detects and signals damage leading to survival or cell death.<br />
The fourth speaker will address how neuronal trophic and communication functions<br />
are maintained by intricate coupling with associated astroglial cells with<br />
emphasis on neurotoxicants that selectively target astroglial cells, rendering<br />
neurons vulnerable to both physiologic and pathophysiologic stresses. The forth<br />
speaker will also summarise the symposium by uncovering similarities and<br />
common themes in the role <strong>of</strong> the cellular environment in determining cell fate<br />
after toxicant insult. This symposium will be <strong>of</strong> interest both to non-experts<br />
looking to understand this field and those with a specific interest in cell biology,<br />
carcinogenesis, neurotoxicology, apoptosis or cell-cell communication.<br />
#1649 1:30 ROLE OF CELL-CELL AND CELL-MATRIX<br />
INTERACTIONS IN REGULATION OF<br />
TOXICANT-MEDIATED CELL DEATH. R.<br />
Roberts 1 and R. Tjalkens 2 . 1 Safety Assessment,<br />
AstraZeneca, Alderley Park, United Kingdom and<br />
2 Department <strong>of</strong> Environmental and Radiological Health<br />
Sciences, Colorado State University, Fort Collins, CO.<br />
#1650 1:40 CELL-CELL INTERACTIONS AND THEIR ROLE<br />
IN TOXICANT-INDUCED HEPATIC CELL<br />
DEATH. R. Roberts. Safety Assessment, AstraZeneca,<br />
Alderley Park, United Kingdom.<br />
#1651 2:20 MODULATION OF CELL-CELL INTERACTIONS<br />
BY EPIGENETIC HEPATOCARCINOGENS. M.<br />
Charbonneau, I. Plante, N. Raynal and D. G. Cyr.<br />
INRS-Institut Armand-Frappier, Universite du Quebec,<br />
Pointe-Claire, Montreal, QC, Canada.<br />
#1652 3:00 THE REGULATION OF APOPTOSIS: SURVIVAL<br />
SIGNALLING AND THE IMPORTANCE OF<br />
CELL TO CELL COMMUNICATION. C. Dive 1,2 , J.<br />
T. Erler 1 , I. J. Stratford 2 , D. A. Tennant 1,3 and D. R.<br />
Tomlinson 3 . 1 Cellular and Molecular Pharmacology<br />
Group, Cancer Research UK Paterson Institute,<br />
Manchester, United Kingdom, 2 School <strong>of</strong> Pharmacy and<br />
Pharmaceutical sciences, University <strong>of</strong> Manchester,<br />
Manchester, United Kingdom and 3 School <strong>of</strong> Biological<br />
Sciences, University <strong>of</strong> Manchester, Manchester, United<br />
Kingdom. Sponsor: R. Roberts.<br />
#1653 3:40 NEURO-GLIAL INTERACTIONS IN BASAL<br />
GANGLIA DYSFUNCTION: INSIGHTS FROM<br />
MANGANESE NEUROTOXICITY. R. Tjalkens.<br />
<strong>Toxicology</strong> Section, Department <strong>of</strong> Environmental and<br />
Radiological Health Sciences, Colorado State<br />
University, Fort Collins, CO.<br />
Wednesday Afternoon, March 9<br />
1:30 PM to 4:30 PM<br />
Room RO4<br />
SYMPOSIUM SESSION: THE UBIQUITIN- PROTEASOME SYSTEM<br />
AS A BIOLOGICAL TARGET IN TOXIC RESPONSES AND DISEASE<br />
Chairperson(s): Richard Pollenz, University <strong>of</strong> South Florida, Tampa, FL and<br />
Elaine M. Faustman, Institute for Risk Analysis & Risk Communication,<br />
Seattle, WA.<br />
Endorsed by:<br />
Mechanisms SS<br />
Neurotoxicology SS<br />
The ubiquitin-proteasome system is an essential pathway involved in covalently<br />
modifying proteins to influence their function and turnover. The cascade is initiated<br />
by an activating enzyme (E1), that binds to the 76 amino acid ubiquitin<br />
protein (UB). The E1 then transfers the UB to an E2 carrier protein. Following<br />
this transfer, a UB ligase enzyme (E3) covalently links the UB to a target<br />
protein. It is the E3, or E3/E2 complex that supplies the target specificity <strong>of</strong> the<br />
ubiquitination event. Genome mining has identified 530 possible genes<br />
encoding E1, E2, E3, UB and deubiquitinating enzymes (DUB). Ubiquinated<br />
substrates are usually recognized by the 20S or 26S proteasome complexes and<br />
destroyed, although recent studies suggest that UB or UB-like modification does<br />
not always result in destruction. The proteasomes are huge multiprotein<br />
complexes that can be found in both the cytoplasm and nucleus. Overall, the<br />
proteasome accounts for 1% <strong>of</strong> a cells protein. Due to the number <strong>of</strong> gene products<br />
required for the ubiquitin-proteasome system, it is a prime target in various<br />
human diseases states and cancer. Defects in the system have been implicated in<br />
neurodegenerative diseases such as Parkinsons and Alzheimers. In addition,<br />
studies continue to suggest that that the various enzymes <strong>of</strong> the pathway may be<br />
targets for toxicologically relevant compounds typified by arsenic, cadmium,<br />
TCDD and ethanol. In addition, the ubiquitin-proteasome system is implicated<br />
in the ligand mediated degradation <strong>of</strong> important transcription factors such as<br />
p53, steroid hormone receptors and the aryl hydrocarbon receptor (AHR). Due<br />
to these findings, the enzymes <strong>of</strong> the ubiquitin-proteasome pathway have<br />
become important targets in toxicology screens and in drug discovery paradigms.<br />
#1654 1:30 THE UBIQUITIN- PROTEASOME SYSTEM AS A<br />
BIOLOGICAL TARGET IN TOXIC RESPONSES<br />
AND DISEASE. R. S. Pollenz. Biology, University <strong>of</strong><br />
South Florida, Tampa, FL.<br />
176<br />
SOT’s 44 th Annual Meeting